Cepheid’s Mpox Test Gets Emergency Use Authorization
The FDA issued an emergency use authorization for the Cepheid Xpert Mpox (monkeypox) test for use in a point-of-care setting.
Read MorePosted by Andy Lundin | Feb 14, 2023 | Emerging & Zoonotic Diseases |
The FDA issued an emergency use authorization for the Cepheid Xpert Mpox (monkeypox) test for use in a point-of-care setting.
Read MorePosted by Andy Lundin | Feb 13, 2023 | Covid 19 |
The FDA issued an Emergency Use Authorization for Anavasi Diagnostics’ AscencioDx COVID-19 Test and The AscencioDx Molecular Detector.
Read MorePosted by Andy Lundin | Feb 10, 2023 | Diagnostic Technologies |
Researchers developed ultrabright fluorescent nanolabels called plasmonic-fluors to overcome limitations in point-of-care diagnostic tests.
Read MorePosted by Andy Lundin | Feb 2, 2023 | Prostate |
Investigators found that the test was able to distinguish cancer localized to the prostate from cancer that spread to other parts of the body.
Read MorePosted by Andy Lundin | Jan 30, 2023 | Diagnostic Technologies, Disease States |
Jana Care and Roche collaborated on a digitally connected, blood testing platform to enable patients to self-administer blood tests at-home.
Read More